IL150822A0 - PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA - Google Patents

PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA

Info

Publication number
IL150822A0
IL150822A0 IL15082201A IL15082201A IL150822A0 IL 150822 A0 IL150822 A0 IL 150822A0 IL 15082201 A IL15082201 A IL 15082201A IL 15082201 A IL15082201 A IL 15082201A IL 150822 A0 IL150822 A0 IL 150822A0
Authority
IL
Israel
Prior art keywords
nhha
proteins
surface antigen
neisseria meningitidis
conserved regions
Prior art date
Application number
IL15082201A
Other languages
English (en)
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of IL150822A0 publication Critical patent/IL150822A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15082201A 2000-01-25 2001-01-25 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA IL150822A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17791700P 2000-01-25 2000-01-25
PCT/AU2001/000069 WO2001055182A1 (en) 2000-01-25 2001-01-25 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA

Publications (1)

Publication Number Publication Date
IL150822A0 true IL150822A0 (en) 2003-02-12

Family

ID=22650445

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15082201A IL150822A0 (en) 2000-01-25 2001-01-25 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
IL150822A IL150822A (en) 2000-01-25 2002-07-18 Proteins Containing Preserved Areas of Meningitis Nisaria NhhA Area Antigens for Use as a Vaccine Against Multiple Strains of Meningitis Nisaria

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150822A IL150822A (en) 2000-01-25 2002-07-18 Proteins Containing Preserved Areas of Meningitis Nisaria NhhA Area Antigens for Use as a Vaccine Against Multiple Strains of Meningitis Nisaria

Country Status (18)

Country Link
US (4) US7947291B2 (cs)
EP (2) EP2395013A3 (cs)
JP (3) JP2003523208A (cs)
KR (1) KR100698561B1 (cs)
CN (2) CN102417537A (cs)
AU (1) AU2818101A (cs)
BR (1) BR0107857A (cs)
CA (1) CA2398139A1 (cs)
CZ (1) CZ304379B6 (cs)
ES (1) ES2389719T3 (cs)
HU (1) HUP0300696A3 (cs)
IL (2) IL150822A0 (cs)
MX (1) MXPA02007184A (cs)
NO (1) NO332229B1 (cs)
NZ (1) NZ520445A (cs)
PL (1) PL216780B1 (cs)
WO (1) WO2001055182A1 (cs)
ZA (1) ZA200206153B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047784B2 (en) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
EP2261338A3 (en) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
WO2000066741A2 (en) * 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens
NZ515935A (en) * 1999-05-19 2004-01-30 Chiron S Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
NZ520445A (en) * 2000-01-25 2004-02-27 Univ Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
NZ521531A (en) 2000-02-28 2005-12-23 Chiron S Heterologous expression of neisserial proteins
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
EP1943269A2 (en) * 2005-10-14 2008-07-16 Intercell AG Neisseria meningitidis antigens
CA2654706A1 (en) 2006-06-12 2007-12-21 Nathalie Devos Neisseria meningitidis lipooligosaccharide vaccine
WO2010070453A2 (en) 2008-12-17 2010-06-24 Novartis Ag Meningococcal vaccines including hemoglobin receptor
EP3017826A1 (en) 2009-03-24 2016-05-11 Novartis AG Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
EP2411048B1 (en) 2009-03-24 2020-05-06 GlaxoSmithKline Biologicals SA Adjuvanting meningococcal factor h binding protein
EP2470205A1 (en) 2009-08-27 2012-07-04 Novartis AG Adjuvant comprising aluminium, oligonucleotide and polycation
CN102596240B (zh) 2009-08-27 2015-02-04 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
CN102724988B (zh) 2009-09-30 2014-09-10 诺华股份有限公司 脑膜炎球菌fHBP多肽的表达
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
WO2011110655A2 (en) 2010-03-11 2011-09-15 Glaxosmithkline Biologicals S.A. Vaccine
AU2011288203A1 (en) 2010-03-18 2012-08-23 Novartis Ag Adjuvanted vaccines for serogroup B meningococcus
AU2011268507B2 (en) 2010-06-25 2014-08-14 Novartis Ag Combinations of meningococcal factor H binding proteins
AU2011284809B2 (en) * 2010-07-30 2015-04-02 Griffith University Recombinant Neisseria meningitidis Por A porin proteins.
US9259462B2 (en) 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
WO2012054879A1 (en) * 2010-10-22 2012-04-26 Duke University Compositions and methods for the treatment of septic arthritis, osteomyelitis, and bacteremia
US20150147356A1 (en) 2011-05-12 2015-05-28 Alan Kimura Antipyretics to enhance tolerability of vesicle-based vaccines
JP2015505309A (ja) 2011-12-29 2015-02-19 ノバルティス アーゲー 髄膜炎菌ｈ因子結合タンパク質のアジュバントされた組み合わせ
EP3299467B1 (en) 2012-02-02 2021-08-11 GlaxoSmithKline Biologicals SA Promoters for increased protein expression in meningococcus
US10598666B2 (en) 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
AU2013276083B2 (en) 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus
JP6324961B2 (ja) 2012-09-06 2018-05-16 ノバルティス アーゲー 血清群ｂ髄膜炎菌とｄ／ｔ／ｐとの組み合わせワクチン
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
SI3544637T1 (sl) 2016-11-25 2021-02-26 Glaxosmithkline Biologicals S.A. Nativni OMV-antigen konjugati in njihova uporaba
BR112019010227A2 (pt) 2016-11-25 2019-10-08 Glaxosmithkline Biologicals S.A. conjugado imunogênico, processo para preparação de conjugado imunogênico, composição imunogênica, vacina, e, uso de nomv
EP4670167A1 (en) * 2023-02-24 2025-12-31 BioNTech SE Systems and methods for modifying synthetic antigens to promote personalized immune responses

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4550081A (en) 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0273116A3 (en) 1986-10-09 1990-05-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Gonococcal and meningococcal polypeptides, vaccines and diagnostics
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
DE58901612D1 (de) 1988-03-24 1992-07-09 Zach Johann Druck- oder kraftmessvorrichtung.
EP0449958B9 (en) * 1988-12-19 2003-05-28 American Cyanamid Company Meningococcal class 1 outer-membrane protein vaccine
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5646259A (en) 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
DK0862656T3 (da) 1995-11-21 2001-04-09 Univ Yale Unimolekylær segmentamplifikation og -detektering
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
CA2671261A1 (en) 1997-11-06 1999-05-20 Novartis Vaccines And Diagnostics S.R.L. Neisserial antigens
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP1047784B2 (en) 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
EP2261338A3 (en) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
WO2000061165A1 (en) * 1999-04-13 2000-10-19 Smithkline Beecham Corporation Conserved adhesin motif and methods of use thereof
ES2323845T3 (es) 1999-04-30 2009-07-27 Novartis Vaccines And Diagnostics, Inc. Secuencias genomicas de neisseria y procedimientos de uso.
WO2000066741A2 (en) * 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
NZ520445A (en) * 2000-01-25 2004-02-27 Univ Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
US20060057160A1 (en) * 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
JP5173194B2 (ja) * 2003-12-23 2013-03-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン

Also Published As

Publication number Publication date
CZ20022482A3 (cs) 2003-01-15
US8367070B2 (en) 2013-02-05
PL356819A1 (en) 2004-07-12
NO20023487L (no) 2002-09-24
CZ304379B6 (cs) 2014-04-09
EP1252182A4 (en) 2005-03-02
US20090068216A1 (en) 2009-03-12
CN102417537A (zh) 2012-04-18
EP2395013A3 (en) 2012-03-21
US8383790B2 (en) 2013-02-26
JP2003523208A (ja) 2003-08-05
NO20023487D0 (no) 2002-07-22
US20090068229A1 (en) 2009-03-12
WO2001055182A1 (en) 2001-08-02
KR20020065938A (ko) 2002-08-14
EP2395013A2 (en) 2011-12-14
EP1252182B1 (en) 2012-06-20
BR0107857A (pt) 2002-10-29
ES2389719T3 (es) 2012-10-30
US7947291B2 (en) 2011-05-24
PL216780B1 (pl) 2014-05-30
JP2014024849A (ja) 2014-02-06
JP2012051902A (ja) 2012-03-15
US20020160016A1 (en) 2002-10-31
NO332229B1 (no) 2012-08-06
NZ520445A (en) 2004-02-27
HUP0300696A2 (hu) 2003-07-28
CA2398139A1 (en) 2001-08-02
CN1419564A (zh) 2003-05-21
IL150822A (en) 2011-06-30
KR100698561B1 (ko) 2007-03-21
AU2818101A (en) 2001-08-07
HUP0300696A3 (en) 2004-10-28
MXPA02007184A (es) 2004-02-26
EP1252182A1 (en) 2002-10-30
US20130136762A1 (en) 2013-05-30
ZA200206153B (en) 2003-11-03

Similar Documents

Publication Publication Date Title
IL150822A0 (en) PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
IL136684A0 (en) Novel surface protein of neisseria meningitidis
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
HUP0204250A3 (en) Use of hiv-protein or -polynucleotide for vaccine produce
CY2011001I1 (el) Εμβολια συνδυασμου για neisseria meningitidis
IL212419A0 (en) Methods of administering anti-tnf antibodies
TW479494U (en) Structure of pillow
PT1305411E (pt) Método de produção de domínios proteicos funcionais
HUP0300099A3 (en) Vaccine for the treatment of artherosclerosis
EP1428828A4 (en) PROCESS FOR THE PRODUCTION OF ALKOXYSILANES
AU8207301A (en) Purification of hbv antigens for use in vaccines
PL367329A1 (en) Methods for reducing immunogenicity of polypeptides
FR2809615B3 (fr) Appareil electromecanique pour assurer le mouvement de flexion/extension des membres inferieurs chez les patients presentant une diminution des fonctions superieures
AU2001267613A1 (en) Adjuvant composition comprising FHA protein or fragment of FHA protein in free form
GB0105606D0 (en) Immunogens and vaccines and their preparation and use
TW567810U (en) Massage pillow
TW492296U (en) Multifunctional pillow for children
TW435705U (en) Glasses foot of eyeglasses
GB0031218D0 (en) Metgod of vaccine preparation
TW496157U (en) Massage chair
TW457913U (en) Construction of disposable pulp-molded pillow
TW435704U (en) Structure improvement of glasses foot for eyeglasses
GB0005728D0 (en) Conserved antigens
GB0130306D0 (en) Method of vaccine preparation
ZA200400228B (en) Therapeutic agents comprising pro-apoptotic proteins